Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Editorial

Kinase Inhibitors in Drug-design, Drug-discovery, and Drug-delivery

Author(s): Vikas Sharma

Volume 30, Issue 13, 2023

Published on: 12 January, 2023

Page: [1463 - 1463] Pages: 1

DOI: 10.2174/092986733013230112163412

Next »
[1]
Kumar, V.; Kaur, N.; Sahu, S.; Sharma, V.; Kumar, D.; Sharma, A.; Wadhwa, P. Role of Tyrosine kinases and their inhibitors in cancer therapy: A comprehensive review. Curr. Med. Chem., 2023, 30(13), 1464-1481.
[2]
Indermun, S.; Kumar, P.; Govender, M.; Choonara, Y.E. Can nanomedicinal approaches provide an edge to the efficacy of tyrosine kinase inhibitors? Curr. Med. Chem., 2023, 30(13), 1482-1501.
[3]
Al-Huseini, I.; Sirasanagandla, S.R.; Babu, K.S.; Sofin, R.G.S.; Das, S. Kinase inhibitors involved in the regulation of autophagy: Molecular concepts and clinical implications. Curr. Med. Chem., 2023, 30(13), 1502-1528.
[4]
Prasher, P.; Sharma, M.; Chan, Y.; Singh, S.K.; Anand, K.; Dureja, H.; Jha, N.K.; Gupta, G.; Zacconi, F.; Chellappan, D.K.; Dua, K. Recent trends in rationally designed molecules as kinase inhibitors. Curr. Med. Chem., 2023, 30(13), 1529-1567.

© 2024 Bentham Science Publishers | Privacy Policy